Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 12/3/2025

Post-Needlestick Hepatitis A Prophylaxis

Immediate Management by Patient Category

  • The Centers for Disease Control and Prevention recommends administering hepatitis A vaccine alone as soon as possible within 14 days of exposure for healthy immunocompetent patients aged 12 months to 40 years 1
  • For patients over 40 years old, the American College of Physicians suggests administering hepatitis A vaccine as soon as possible and considering adding immune globulin based on provider risk assessment 1, 2
  • The Advisory Committee on Immunization Practices recommends administering both hepatitis A vaccine and immune globulin simultaneously at different anatomic sites for immunocompromised patients or those with chronic liver disease 1, 2
  • For infants under 12 months, the American Academy of Pediatrics recommends administering immune globulin alone 1

Critical Timing Considerations

  • The Centers for Disease Control and Prevention states that prophylaxis must be administered within 14 days of exposure for any efficacy, with earlier administration being better 1, 3, 5
  • The World Health Organization notes that no data support efficacy beyond 2 weeks post-exposure 3, 5, 4

Important Clinical Caveats

  • The Advisory Committee on Immunization Practices recommends using single-antigen hepatitis A vaccine only, such as Havrix or Vaqta, for post-exposure prophylaxis 3, 5, 2
  • The Centers for Disease Control and Prevention advises against using combination hepatitis A/B vaccine for post-exposure prophylaxis due to limited data supporting its use 3, 5, 2

Evidence Quality and Nuances

  • The 2018 Advisory Committee on Immunization Practices guidelines represent the most current and authoritative recommendations for post-needlestick hepatitis A prophylaxis, superseding earlier 2007 guidelines 1, 3, 5, 4, 2